Skin whitening composition comprising Cantharellus applanatus extract as an active ingredient
A skin whitening composition using Cantarelles aplanatus mushroom extract addresses the need for natural, safe, and effective skin lightening by inhibiting melanin synthesis and protein expression, offering a viable alternative to synthetic compounds.
Patent Information
- Application Number
- KR1020240150938
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2024-10-30
- Publication Date
- 2026-11-11
- Estimated Expiration
- 2044-10-30
AI Technical Summary
Existing skin whitening products often rely on synthetic compounds that can be harmful and lack effective natural alternatives with proven skin whitening effects, particularly from mushrooms native to Korea.
A skin whitening composition utilizing an extract of Cantarelles aplanatus mushroom, extracted using a mixed solution of ethanol and water, followed by ethyl acetate, which inhibits melanin synthesis, tyrosinase activity, and the expression of melanin formation-related proteins.
The composition exhibits excellent skin whitening effects with low cytotoxicity, inhibiting melanin synthesis and protein expression in a concentration-dependent manner, providing safe and effective skin lightening.
Smart Images

Figure 112024118827164-PAT00002_ABST
Abstract
Description
Technology Field
[0001] The present invention relates to the Cantarelles aplanatus mushroom ( Cantharellus applanatus The present invention relates to a skin whitening composition containing an extract of ) as an active ingredient. More specifically, the present invention relates to a skin whitening composition that utilizes a mushroom native to Korea and has low cytotoxicity, and can exhibit excellent skin whitening effects such as inhibiting melanin synthesis in skin cells, inhibiting tyrosinase activity, and inhibiting the expression of proteins related to melanin formation, and a method for producing a substance capable of exhibiting such excellent skin whitening activity using a mushroom native to Korea. Background Technology
[0003] Whitening, which involves making the skin beautiful and white, is a topic of great interest in the field of functional cosmetics, and accordingly, the discovery of substances capable of exhibiting such whitening effects is actively underway. Generally, inhibiting the formation of melanin is crucial for achieving a whitening effect. Therefore, substances with excellent whitening effects can be identified by investigating the regulatory effects on melanin formation, and the whitening effect of candidate substances can be confirmed by investigating the influence on the activity and / or expression of tyrosinase, an enzyme involved in the initial stages of melanin production, as a related factor. Additionally, other factors known to be involved in melanin production, such as TRP-1 (tyrosinase-related protein 1), TRP-2 (tyrosinase-related protein 2), and MITF (microphthalmia-associated transcription factor), can also be used to investigate their influence.
[0004] Meanwhile, due to environmental pollution issues and potential harm to the human body, efforts are being made to utilize natural resources instead of synthetic compounds as functional substances. Mushrooms are also one of these natural resources, possessing high potential for utilization. Consequently, while research on the physiological activity of mushrooms is being conducted, relevant studies remain insufficient. Accordingly, the inventors investigated the possibility of exhibiting excellent skin whitening effects by effectively controlling the skin whitening-related activities described above from various mushrooms, particularly those native to Korea. Prior art literature
[0006] Korean Registered Patent No. 10-1437059 Korean Registered Patent No. 10-1402193 The problem to be solved
[0007] The main objective of the present invention is to provide a skin whitening composition capable of exhibiting an excellent skin whitening effect by utilizing mushrooms, which are natural resources, particularly mushrooms native to Korea.
[0008] Another objective of the present invention is to provide a method for producing a substance having excellent skin whitening activity by utilizing the mushroom. means of solving the problem
[0010] In one aspect, the present invention provides a skin whitening composition according to the following item:
[0011] 1. Cantarelles aplanatus mushroom ( Cantharellus applanatus A skin whitening composition containing an extract of ) as an active ingredient.
[0012] 2. A skin whitening composition according to Item 1, wherein the extract is extracted with a mixed solution of ethanol and water.
[0013] 3. A skin whitening composition according to Item 1 or Item 2, wherein the extract is extracted with a 50 to 90% (v / v) aqueous ethanol solution.
[0014] 4. A skin whitening composition according to Item 2 or Item 3, wherein the extract is further extracted with ethyl acetate after the extraction.
[0015] In another aspect, the present invention provides a method for producing a skin whitening active substance according to the following item:
[0016] 5. A method for producing a skin whitening active substance comprising the step of extracting Cantarelles aplanatus mushroom by adding a solvent.
[0017] 6. A method for producing a skin whitening active substance, wherein the solvent in Item 5 is a mixed solution of ethanol and water.
[0018] 7. A method for producing a skin whitening active substance, wherein, in item 5 or item 6, the solvent is a 50 to 90% (v / v) aqueous ethanol solution.
[0019] 8. A method for producing a skin whitening active substance, wherein, in item 6 or item 7, after the extraction step, the method further comprises the step of adding ethyl acetate to the extract obtained in the extraction step to extract. Effects of the invention
[0021] According to the present invention, a skin whitening composition is provided that utilizes mushrooms native to Korea, has low cytotoxicity for safe use, and exhibits excellent skin whitening effects such as inhibiting melanin synthesis in skin cells, inhibiting tyrosinase activity, and inhibiting the expression of melanin formation-related proteins (MITF, TRP-1, TRP-2, and tyrosinase). Additionally, a method is provided to produce a substance capable of exhibiting such excellent skin whitening activity using mushrooms native to Korea. Brief explanation of the drawing
[0023] FIG. 1 shows the results of a toxicity test on skin cells (B16F10 melanoma cells) of Cantarelles aplanatus mushroom extract according to one embodiment of the present invention. "extract", Cantarelles aplanatus mushroom extract; "Kojic acid", kojic acid used as a control group. FIG. 2 shows the experimental results of the melanin synthesis inhibitory activity of Cantarelles aplanatus mushroom extract according to one embodiment of the present invention. "extract", Cantarelles aplanatus mushroom extract; "Kojic acid", kojic acid used as a control group. FIG. 3 shows the experimental results of the tyrosinase activity inhibitory activity of Cantarelles aplanatus mushroom extract according to one embodiment of the present invention. "extract", Cantarelles aplanatus mushroom extract; "Kojic acid", kojic acid used as a control group. FIGS. 4 to 7 each show the experimental results of the inhibitory activity of Cantarelles aplanatus mushroom extract on MITF, TRP-1, TRP-2, and tyrosinase protein expression according to an embodiment of the present invention. "extract", Cantarelles aplanatus mushroom extract. Specific details for implementing the invention
[0024] The skin whitening composition of the present invention is Cantarelles aplanatus mushroom ( Cantharellus applanatus It is characterized by containing an extract of ) as an active ingredient.
[0025] Cantarellarus aplanatus is a species of the genus Cantarella, belonging to the family Hydnaceae of the order Cantarellales. The cap of this mushroom is yellow with a diameter of 3 to 8 cm and has an irregular wavy margin; the hymenium is decurrent, and the stem is the same color as the cap or lighter. The stem attachment is eccentric or centric. The gills are venous. In the present invention, for the effect intended by the present invention, a strain naturally growing in Korea or isolated therefrom is preferably used.
[0026] The extract of the present invention may be prepared using Cantarelles aplanatus mushroom as an extraction raw material according to an extraction method commonly used in the field. For example, it may be extracted using a polar solvent or a non-polar solvent. In this case, the polar solvent may be selected from the group consisting of lower alcohols having 1 to 4 carbon atoms and water, and the non-polar solvent may be selected from the group consisting of chloroform, petroleum ether, ether, butanol, hexane, toluene, and the like. For the effect intended in the present invention, the extract of the present invention is preferably extracted using water, alcohols having 1 to 4 carbon atoms and a mixed solution thereof as a solvent, more preferably extracted using water, ethanol, or a mixed solution thereof as a solvent, and even more preferably extracted using a mixed solution of water and ethanol as a solvent. For the effect intended in the present invention, extraction is performed using a solvent of 10 to 90% (v / v) ethanol aqueous solution, more preferably 30 to 90% (v / v) ethanol aqueous solution, more preferably 50 to 90% (v / v) ethanol aqueous solution, more preferably 60 to 80% (v / v) ethanol aqueous solution, and more preferably 65 to 75% (v / v) ethanol aqueous solution.
[0027] When extracting, for example, 1 to 20 times the weight of the solvent can be used relative to the weight of the dry material of Cantarelles aplanatus mushroom, which is the raw material for extraction, and preferably 5 to 15 times the weight of the solvent.
[0028] The extraction temperature can be set, for example, from 0 to 120°C, and for the effect intended in the present invention, it is preferably set from 20 to 100°C, more preferably from 30 to 90°C, more preferably from 40 to 80°C, and more preferably from 50 to 70°C.
[0029] The extraction time can be set to, for example, 1 to 100 hours, preferably 24 to 72 hours, more preferably 36 to 60 hours, and more preferably 40 to 55 hours.
[0030] In addition, the extract can be obtained by repeating the extraction process, for example, by separating and recovering the extract from the residue after the first extraction, adding a new solvent to the residue to perform a second extraction, and obtaining the extract again. When the extraction is repeated, the number of repetitions can be, for example, 2 to 5 times, preferably 2 to 4 times, more preferably 2 to 3 times, and more preferably 2 times.
[0031] The extract of the present invention may be filtered after extraction as described above. Additionally, the extract of the present invention may be a product that has undergone additional processes such as concentration, vacuum drying, and freeze-drying after filtration, for example, a freeze-dried powder.
[0032] In addition, for the effect intended in the present invention, the extract of the present invention may more preferably be obtained by extracting using a mixed solution of ethanol and water as a solvent and then further extracting with ethyl acetate. Preferably, such an extract is obtained by obtaining an extract using a mixed solution of ethanol and water as a solvent under conditions as described above, dissolving or suspending it in water, adding ethyl acetate thereto and mixing, then allowing it to stand to separate into layers, obtaining the ethyl acetate layer therefrom, and removing the ethyl acetate solvent.
[0033] According to research results, the Cantarelles aplanatus mushroom extract of the present invention may exhibit little cytotoxicity to skin cells even at high concentrations. For example, when B16F10 skin cells were treated at a concentration of 100 μg / ml, they could show a cell survival rate of over 95% compared to control B16F10 cells. In addition, the Cantarelles aplanatus mushroom extract of the present invention can inhibit melanin synthesis in skin cells in a concentration-dependent manner, inhibit tyrosinase activity in a concentration-dependent manner, and suppress the expression of melanin formation-related proteins, such as MITF, TRP-1, TRP-2, and tyrosinase, in a concentration-dependent manner.
[0034] The above-mentioned factors, namely melanin, tyrosinase, MITF, TRP-1, TRP-2, etc., are important factors for skin whitening, and the Cantarelles aplanatus mushroom extract of the present invention can exhibit an excellent skin whitening effect by effectively controlling these factors.
[0035] The skin whitening composition of the present invention may include the Cantarelles aplanatus mushroom extract of the present invention in various amounts depending on various purposes such as the form and use of the composition. For example, the Cantarelles aplanatus mushroom extract of the present invention may be contained in the composition in an amount of, for example, 0.01 to 100% by weight based on dry weight, but is not limited thereto.
[0036] The skin whitening composition of the present invention may contain only the Cantarella aplanatus mushroom extract of the present invention as an active ingredient, and may also contain other skin whitening active substances.
[0037] In one embodiment, the skin whitening composition of the present invention contains only the Cantarelles aplanatus mushroom extract of the present invention as an active ingredient and does not contain other skin whitening active substances, such as other compounds and / or extracts known to have skin whitening activity.
[0038] In another embodiment, the skin whitening composition of the present invention further contains other skin whitening active substances, such as other compounds and / or extracts known to have skin whitening activity, together with the Cantarella aplanatus mushroom extract of the present invention.
[0039] The skin whitening composition of the present invention may be a cosmetic composition for skin whitening.
[0040] The skin whitening composition of the present invention may be the Cantarelleus aplanatus mushroom extract of the present invention itself, or a composition mixed with a carrier that is pharmaceutically, food- or cosmetically acceptable.
[0041] The skin whitening composition of the present invention may be prepared in cosmetic formulations commonly manufactured in the field. For example, it may be formulated as a solution, suspension, emulsion, powder, paste, gel, cream, etc., but is not limited thereto. More specifically, it may be prepared in the form of a softening lotion, a nourishing lotion, a nourishing cream, a massage cream, an essence, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray, or a powder.
[0042] The skin whitening composition of the present invention may be used alone or in combination with other skin products.
[0043] The method for producing a skin whitening active substance according to the present invention is characterized by including the step of extracting Cantarelles aplanatus mushroom by adding a solvent.
[0044] The above extraction step may be a step of extracting according to an extraction method commonly used in the field using Cantarelles aplanatus mushroom as an extraction raw material. For example, it may be a step of extracting using a polar solvent or a non-polar solvent. In this case, the polar solvent may be selected from the group consisting of lower alcohols having 1 to 4 carbon atoms and water, and the non-polar solvent may be selected from the group consisting of chloroform, petroleum ether, ether, butanol, hexane, toluene, and the like. For the effect intended in the present invention, the above extraction step is preferably a step of extracting using water, alcohols having 1 to 4 carbon atoms and a mixed solution thereof as a solvent, more preferably a step of extracting using water, ethanol or a mixed solution thereof as a solvent, and more preferably a step of extracting using a mixed solution of water and ethanol as a solvent. For the effect intended in the present invention, the step of extraction is more preferably performed using a 10 to 90% (v / v) aqueous ethanol solution as a solvent, more preferably using a 30 to 90% (v / v) aqueous ethanol solution, more preferably using a 50 to 90% (v / v) aqueous ethanol solution, more preferably using a 60 to 80% (v / v) aqueous ethanol solution, and more preferably using a 65 to 75% (v / v) aqueous ethanol solution as a solvent.
[0045] In addition, the extraction step may be a step of extracting using, for example, 1 to 20 times the weight of a solvent relative to the weight of the dried material of Cantarelles aplanatus mushroom, which is the extraction raw material, and preferably a step of extracting using 5 to 15 times the weight of a solvent for the effect intended in the present invention.
[0046] In addition, the extraction step may be a step of extraction at an extraction temperature of, for example, 0 to 120°C, and for the effect intended in the present invention, preferably a step of extraction at an extraction temperature of 20 to 100°C, more preferably 30 to 90°C, more preferably 40 to 80°C, and more preferably 50 to 70°C.
[0047] In addition, the extraction step may be an extraction step for, for example, 1 to 100 hours, preferably an extraction step for 24 to 72 hours, more preferably 36 to 60 hours, and more preferably 40 to 55 hours.
[0048] In addition, the extraction step may be a step of obtaining an extract by repeating the extraction, for example, by separating and recovering the extract from the residue after the first extraction, adding a new solvent to the residue to perform a second extraction, and obtaining the extract again. When the extraction is repeated, the number of repetitions may be, for example, 2 to 5 times, preferably 2 to 4 times, more preferably 2 to 3 times, and more preferably 2 times.
[0049] The method for producing a skin whitening active substance of the present invention may further include a filtration step after the extraction step as described above. Additionally, the method for producing a skin whitening active substance of the present invention may further include concentration, vacuum drying, and / or freeze-drying steps after the filtration step.
[0050] In addition, the method for producing a skin whitening active substance of the present invention may, more preferably for the effect intended in the present invention, further include a step of extracting using a mixed solution of ethanol and water as a solvent, followed by a step of adding ethyl acetate to the extract obtained therefrom to extract. This ethyl acetate extraction step is preferably a step of dissolving or suspending the extract obtained using a mixed solution of ethanol and water as a solvent in water, adding ethyl acetate thereto and mixing, then allowing it to stand to separate into layers, thereby obtaining an ethyl acetate layer, and removing the ethyl acetate solvent.
[0052] The present invention will be described in more detail below through examples. These examples are merely illustrative of the present invention, and therefore the scope of the present invention should not be interpreted as being limited by these examples.
[0054] [Example]
[0055] Example 1. Preparation of Cantarelleus aplanatus mushroom extract
[0056] Cantarelles aplanatus mushrooms were collected on August 10, 2022, from a walking trail in a mixed forest of conifers and deciduous trees within the Comprehensive Environmental Research Complex in Gyeongseo-dong, Seo-gu, Incheon.
[0057] Mushrooms were dried and ground, and 1 g of the ground material was extracted with 10 times its weight of 70% (v / v) ethanol at 60°C for 48 hours, and this process was repeated twice. The recovered extract was filtered using a paper filter (ADVANTEC, Tokyo, Japan), concentrated under reduced pressure, and then powdered by freeze-drying (HC3110, Hanil Scientific Inc., Gimpo, Korea). Subsequently, 100 mg of the dried powder sample was suspended in distilled water and extracted with ethyl acetate for use in the experiment.
[0059] Example 2. Evaluation of whitening activity
[0060] 2-1. Method
[0061] 2-1-1. Experimental Materials and Cell Culture
[0062] B16F10 melanoma cells were obtained from ATCC (American Type Cell Culture, Manassas, Virginia, USA), and α-MSH (α-melanocyte stimulating hormone) and L-DOPA (L-3,4-dihydroxyphenylalanine) were purchased from Sigma-Aldrich (St. Louis, Missouri, USA). B16F10 melanoma cells were cultured in DMEM (Dulbecco's Modified Eagle's Medium) (Welgene) medium containing 10% FBS (fetal bovine serum) (Welgene, Gyeongsan, Korea) and 100 µg / ml streptomycin in a 37°C, 5% CO2 incubator, and were used for experiments after stabilization through subculture every 3 days.
[0064] 2-1-2. Measurement of Cytotoxicity
[0065] Cytotoxicity was evaluated in B16F10 melanoma cells induced with α-MSH using the thiazolyl blue tetrazolium bromide assay (MTT assay). 1.0 × 10⁶ cells were placed in a 24-well plate. 4 B16F10 melanoma cells were seeded at cell / well ratios and cultured for 24 hours in a 37°C, 5% CO2 incubator. Then, α-MSH (200 nM) and the extract sample of Example 1 (ethyl acetate fraction of the ethanol-extracted extract) were simultaneously treated at concentrations of 25, 50, and 100 μg / ml and cultured for 72 hours. Afterward, MTT reagent was added to each well and reacted for 3 hours in a 37°C, 5% CO2 incubator. The supernatant was then removed, and the formed pellet was dissolved in DMSO (dimethyl sulfoxide), transferred to a 96-well plate, and the absorbance was measured at 570 nm using an ELISA reader.
[0067] 2-1-3. Measurement of Melanin Synthesis Inhibitory Activity
[0068] To evaluate melanin synthesis inhibitory activity, B16F10 melanoma cells were 4.0×10 4 Cells were dispensed into a 6-well plate at a cell / well ratio and cultured for 24 hours in a 37°C, 5% CO2 incubator. Then, the extract samples of Example 1 (25, 50, 100 μg / mL) and α-MSH (200 nM) were added simultaneously, and the cells were cultured for 72 hours. After 72 hours, trypsin was added to suspend the cells, and then RIPA buffer (1% protease inhibitor, Bio-Rad, Hercules, California, USA) was added to lyse them. Subsequently, the supernatant was removed by centrifugation at 4°C and 13,000 rpm for 30 minutes. Afterward, 500 μl of 1N NaOH was added to the recovered pellet and heated at 90°C for 1 hour. The pellet was then transferred to a 96-well plate, and the absorbance was measured at 405 nm using an ELISA reader.
[0070] 2-1-4. Measurement of Tyrosinase Activity
[0071] To confirm whether the extract of the present invention possesses activity that inhibits tyrosinase, an enzyme that plays an important role in melanin synthesis, 4.0 × 10⁶ B1610 melanoma cells were placed in a 6-well plate. 4Cells were dispensed into wells and cultured for 24 hours in a 37°C, 5% CO2 incubator. Then, the extract samples of Example 1 (25, 50, 100 μg / ml) and α-MSH (200 nM) were added simultaneously and cultured for 72 hours. After 72 hours, the cells were detached from the plate using trypsin and lysed with RIPA buffer. The supernatant was collected by centrifuging at 4°C and 13,000 rpm for 30 minutes. After quantifying the protein content of the supernatant using a BCA kit (Thermo Fisher Scientific), 20 μl of the quantified protein and 80 μl of L-DOPA prepared at 2 mg / ml were added to a 96-well plate. The reaction was carried out in the dark for 2 hours, and the absorbance was measured at 490 nm using an ELISA reader.
[0073] 2-1-5. Western Blot Analysis
[0074] MITF, TRP-1, TRP-2, and tyrosinase are important proteins in melanin synthesis; to measure their expression levels, 4.0 × 10⁶ were placed in a 6-well plate. 4B16F10 melanoma cells were seeded into a cell / well plate and cultured for 48 hours in a 7°C, 5% CO2 incubator. Then, α-MSH (200 nM) and the extract samples of Example 1 (25, 50, 100 μg / ml) were added simultaneously and cultured for 24 hours. Subsequently, cells were separated from the plate by trypsin treatment and lysed with RIPA buffer. The supernatant was then obtained by centrifugation at 4°C, 13,000 rpm for 30 minutes. The protein content of the supernatant was quantified using a BCA kit, and the quantified proteins were separated by electrophoresis on 10% SDS-PAGE. After electrophoresis, the protein was transferred to a poly-vinylidene difluoride membrane (Milipore, Burlington, Massachusetts, USA), and the membrane was placed in a solution containing 5% skim milk in 1× TBST and blocked at room temperature for 2 hours. Subsequently, the primary antibodies MITF (1:500, Santa Cruz Biotechnology, Dallas, Texas, USA), TRP-1, TRP-2, and tyrosinase (1:1,000, Santa Cruz Biotechnology) were reacted at 4°C for 18 hours, followed by washing with TBST four times for 10 minutes. The secondary antibodies were anti-mouse IgG HRP and anti-rabbit IgG secondary antibodies (Cell Signaling Technology, Inc., Danvers, Massachusetts, USA) diluted to 1:10,000 and reacted at room temperature for 2 hours, followed by washing with TBST four times for 10 minutes. The phenomenon was performed using an ECL kit (Bio-rad) and an imaging densitometer (model GS-700, Bio-rad), and the expression levels of TRP-1, TRP-2, tyrosinase, and MITF proteins relative to β-actin were quantified using the Image J program (NIH, Bethesda, Maryland, USA) and displayed as a graph.
[0076] 2-1-6. Statistical Processing
[0077] All results were expressed as mean and standard deviation through three repeated experiments, and statistical significance was tested using a t-test following analysis of variance (ANOVA), at levels of *p<0.05, **p<0.01, and ***p<0.001.
[0079] 2-2. Results
[0080] 2-2-1. Measurement of Cytotoxicity
[0081] As a result of performing an MTT assay to determine whether the extract of *Cantarella aplanatus* mushroom affects the viability of B16F10 melanoma cells, when the extract samples of Example 1 were treated at concentrations of 25, 50, and 100 μg / ml, respectively, a cell viability of over 95% was observed at the corresponding concentrations (Fig. 1). This demonstrates the safety of the composition of the present invention.
[0083] 2-2-2. Evaluation of Melanin Synthesis Inhibitory Activity
[0084] When B16F10 melanoma cells were treated with Cantarelles aplanatus mushroom extract to determine the effect on melanin production, it was found that compared to a group in which melanin synthesis was induced by α-MSH alone, the extract samples of Example 1 were treated at concentrations of 25, 50, and 100 μg / ml, respectively, inhibiting melanin synthesis by 36%, 58%, and 59%, respectively (Fig. 2). This demonstrates that the composition of the present invention can effectively inhibit melanin synthesis in skin cells and provide an excellent whitening effect.
[0086] 2-2-3. Evaluation of Tyrosinase Inhibitory Activity
[0087] Tyrosinase is a copper-containing enzyme involved in melanin biosynthesis in vertebrates. Accordingly, tyrosinase activity was evaluated by treating with Cantarelles aplanatus mushroom extract. When the extract samples of Example 1 were treated at concentrations of 50 and 100 μg / ml, respectively, the tyrosinase activity increased by α-MSH (200 nM) was inhibited by 33% and 65%, respectively. In particular, when treated at a concentration of 100 μg / ml, it was found that tyrosinase activity was inhibited to a level similar to that of the α-MSH untreated group (Fig. 3). This demonstrates that the composition of the present invention can effectively inhibit the tyrosinase activity of skin cells and provide an excellent whitening effect.
[0089] 2-2-4. Measurement of the inhibitory activity of MITF, TRP-1, TRP-2, and tyrosinase protein expression
[0090] Melanin synthesis is directly catalyzed by tyrosinase, TRP-1, and TRP-2, and MITF regulates the production of these enzymes as a major transcription factor of proteins related to melanin synthesis. Accordingly, when the effect of Cantarelles aplanatus mushroom extract on the expression of these proteins was investigated by Western blot, concentration-dependent inhibition of the expression of these proteins was confirmed upon treatment with the extract sample of Example 1. In particular, when treated at a concentration of 100 μg / ml, the expression of MITF was inhibited by 44.8%, the expression of TRP-1 by 53.7%, and the expression of TRP-2 and tyrosinase by 53.9% and 44.1%, respectively (Figs. 4 to 7). This demonstrates that the composition of the present invention can effectively inhibit the expression of proteins related to melanin synthesis in skin cells, thereby providing an excellent whitening effect.
Claims
Claim 1 Cantarelles aplanatus mushroom ( Cantharellus applanatus A skin whitening composition containing an extract of ) as an active ingredient. Claim 2 A skin whitening composition according to claim 1, wherein the extract is obtained by extracting with a mixed solution of ethanol and water. Claim 3 A skin whitening composition according to paragraph 2, wherein the extract is extracted with a 50 to 90% (v / v) aqueous ethanol solution. Claim 4 A skin whitening composition according to paragraph 2, wherein the extract is additionally extracted with ethyl acetate after the extraction. Claim 5 A method for producing a skin whitening active substance comprising the step of extracting Cantarelles aplanatus mushroom by adding a solvent. Claim 6 A method for producing a skin whitening active substance according to claim 5, wherein the solvent is a mixed solution of ethanol and water. Claim 7 A method for producing a skin whitening active substance according to claim 6, wherein the solvent is a 50 to 90% (v / v) aqueous ethanol solution. Claim 8 A method for producing a skin whitening active substance according to claim 6, further comprising, after the extraction step, a step of adding ethyl acetate to the extract obtained in the extraction step to extract.
Citation Information
Patent Citations
The composition comprising the extracts of Ramaria formosa(Fr.) Quel for prevention of skin whitening as an active ingredient
KR101898345B1
Composition containing an extract of a sequential or simultaneous fermentation
KR1020140094563A
A whitening composition comprising pleurotus nebrodensis extract
KR1020210091540A
